
pmid: 12582472
Available systemically effective antifungal agents for the treatment of invasive fungal infections are few. With the increasing recognition of a need for newer antifungal drugs, caspofungin has been introduced as the first member of a new class of compounds called echinocandins. This paper reviews the chemistry and mechanism of action of caspofungin, its activity in vitro and in animal models, and clinical pharmacokinetics,clinical efficacy and safety in patients.
Clinical Trials as Topic, Antifungal Agents, Dose-Response Relationship, Drug, Fungi, Drug Resistance, Microbial, Peptides, Cyclic, Anti-Bacterial Agents, Echinocandins, Lipopeptides, Mycoses, Caspofungin, Animals, Humans, Drug Interactions, Drug Therapy, Combination, Renal Insufficiency, Peptides, Liver Failure
Clinical Trials as Topic, Antifungal Agents, Dose-Response Relationship, Drug, Fungi, Drug Resistance, Microbial, Peptides, Cyclic, Anti-Bacterial Agents, Echinocandins, Lipopeptides, Mycoses, Caspofungin, Animals, Humans, Drug Interactions, Drug Therapy, Combination, Renal Insufficiency, Peptides, Liver Failure
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 21 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
